Tata 1mg Reports FY25 Net Loss Reduction, Revenue Growth
Tata 1mg, a leading digital healthcare platform, has reported a significant reduction in its net loss for FY25. Despite a Rs 276 crore loss, the company showed a 22% year-on-year growth in consolidated revenue to Rs 2,392 crore. Meanwhile, Tata Digital, the group's digital commerce arm, reported a standalone revenue of Rs 546.9 crore and a loss of Rs 827.5 crore.
Tata 1mg Technologies, the digital arm of the company, contributed Rs 375.5 crore to the topline, while Tata 1mg Healthcare Solutions added Rs 2,016.5 crore. The company's total expenses rose 17% to Rs 2,682 crore in FY25. Tata 1mg's current cash burn of Rs 180-200 crore annually is being used to expand offline stores in cities like Gurugram, Noida, Lucknow, and Jaipur.
Tata Digital increased its stake in Tata 1mg to about 67% as of FY25. The company's last reported valuation was $1.25 billion. Tata 1mg has launched a brick-and-mortar retail strategy to deepen its market footprint and accelerate medicine delivery.
Tata 1mg's efforts to expand its offline presence and reduce net losses have shown promising results. Despite the increase in total expenses, the company's revenue growth and reduced net loss indicate a positive trajectory. The company's digital-first approach, coupled with its brick-and-mortar expansion, is expected to further strengthen its position in the healthcare market.
Read also:
- Planned construction of enclosures within Görlitzer Park faces delays
- Controversy resurfaces following the elimination of diesel filter systems at Neckartor: A renewed conflict over the diesel restriction policy
- Perennial Seeks Growth Marketing & GTM Associate for Carbon Removal Mission
- Foreign financial aid for German citizens residing abroad persists
